Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria

Published:2014-04-29 Issue:9 Volume:61 Page:1544-1550
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Reiss Ulrike M.¹,Schwartz Jeffrey²,Sakamoto Kathleen M.³,Puthenveetil Geetha⁴,Ogawa Masayo⁵,Bedrosian Camille L.⁵,Ware Russell E.⁶

Affiliation:

1. Department of Hematology; St. Jude Children's Research Hospital; Memphis Tennessee

2. Nemour's Children's Clinic; Pensacola Florida

3. Department of Pediatrics; Stanford University; Stanford California

4. Department of Pediatrics; Children's Hospital of Orange County; Orange California

5. Alexion Pharmaceuticals, Inc.; Cheshire Connecticut

6. Department of Pediatrics; University of Cincinnati; Cincinnati Ohio

Funder

Alexion Pharmaceuticals

ALSAC

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.25068/fullpdf

Reference43 articles.

1. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria;Takeda;Cell,1993

2. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis;Miyata;Science,1993

3. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9;Rollins;J Immunol,1990

4. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes;Medof;J Exp Med,1984

5. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease;Rother;JAMA,2005

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for optimising the diagnosis and treatment of paroxysmal nocturnal haemoglobinuria in Singapore;Annals of the Academy of Medicine, Singapore;2024-06-28

2. Exploring treatment strategies for paroxysmal nocturnal hemoglobinuria: an overview of registered clinical trials;Current Medical Research and Opinion;2024-05-16

3. Farmacocinética de eculizumab en pacientes adultos y pediátricos con síndrome hemolítico urémico atípico y glomerulopatía C3;Farmacia Hospitalaria;2024-01

4. [Translated article] Pharmacokinetics of eculizumab in adult and pediatric patients with atypical hemolytic uremic syndrome and C3 glomerulopathy;Farmacia Hospitalaria;2024-01

5. Efficacy and safety of current treatments for paroxysmal nocturnal hemoglobinuria: A systematic review;Clinical Immunology Communications;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3